跳至主要内容
临床试验/CTRI/2021/02/031565
CTRI/2021/02/031565招募中未知

An Investigator initiated, open label, single arm prospective study to evaluate the safety, tolerability and efficacy of Fluconazole in Pediatric subjects suffering from Tinea Corporis, Tinea Cruris, Tinea Capitis or Tinea Faciei Infections - CT-Fzole-Derma- 2020

Dr Rajeev Sharma0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male or Female Pediatric patients with age up to 18 years old.
  • 2. Pediatric patients who are diagnosed with Tinea infections confirmed
  • by positive KOH

排除标准

  • 1.Patients suffering from underlying immunosuppression
  • 2.Patients with Secondarily infected lesions or eczematized lesions
  • 3.Patients who received any type of anti-fungal therapy within last 7 days
  • 4.Patients who applied any other topical agent over the lesions within last 7 days
  • 5.Patients with renal dysfunction
  • 6.Patients with liver dysfunction
  • 7.Patient having history of resistance to Fluconazole

研究者

发起方
Dr Rajeev Sharma

相似试验